ANDA 62505, held by Chartwell. Doxycycline Hyclate.
As of Nov 16, 2026, ANDA 62505 (Doxycycline Hyclate), held by Chartwell, was first approved by FDA on Sep 11, 1984, with 38 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline and other antibacterial drugs, doxycycline should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 11, 1984 | Original application | Approved | None posted |
| Doxycycline HyclateEQ 100MG BASE · tablet;oral | Doxycycline Hyclate | Rx |
| Doxycycline HyclateEQ 50MG BASE · tablet;oral | Doxycycline Hyclate | Rx |
| Mar 31, 2025 | Supplement 84Labeling · Standard review | Approved | None posted |
| Jul 27, 2021 | Supplement 81Manufacturing | Approved | None posted |
| Jul 21, 2021 | Supplement 80Labeling · Standard review | Approved | None posted |
| Jul 21, 2021 | Supplement 78Labeling · Standard review | Approved | None posted |
| Jul 21, 2021 | Supplement 77Labeling · Standard review | Approved | None posted |
| Dec 2, 2014 | Supplement 70Labeling · Standard review | Approved | None posted |
| Apr 25, 2012 | Supplement 68Labeling | Approved | None posted |
| Jun 30, 2008 | Supplement 59Labeling | Approved | None posted |
| Mar 28, 2006 | Supplement 56Labeling | Approved | None posted |
| Apr 26, 2005 | Supplement 39Labeling | Approved | None posted |
| Jul 27, 2004 | Supplement 37Labeling | Approved | None posted |
| Dec 9, 2002 | Supplement 34Manufacturing | Approved | None posted |
| Apr 11, 2002 | Supplement 33Labeling | Approved | None posted |
| Mar 20, 2002 | Supplement 31Manufacturing | Approved | None posted |
| Mar 20, 2002 | Supplement 30Manufacturing | Approved | None posted |
| Mar 20, 2002 | Supplement 29Manufacturing | Approved | None posted |
| Dec 21, 2001 | Supplement 32Manufacturing | Approved | None posted |
| Sep 12, 2001 | Supplement 27Manufacturing | Approved | None posted |
| Jul 26, 2000 | Supplement 26Labeling | Approved | None posted |
| Jul 26, 2000 | Supplement 25Manufacturing | Approved | None posted |
| Jan 28, 2000 | Supplement 24Manufacturing | Approved | None posted |
| Aug 20, 1999 | Supplement 23Manufacturing | Approved | None posted |
| Jul 8, 1999 | Supplement 22Manufacturing | Approved | None posted |
| Jul 8, 1999 | Supplement 21Manufacturing | Approved | None posted |
| Jul 8, 1999 | Supplement 20Manufacturing | Approved | None posted |
| Jul 8, 1999 | Supplement 19Manufacturing | Approved | None posted |
| Jul 8, 1999 | Supplement 18Manufacturing | Approved | None posted |
| Dec 9, 1998 | Supplement 17Manufacturing | Approved | None posted |
| Sep 4, 1998 | Supplement 16Manufacturing | Approved | None posted |
| Dec 22, 1997 | Supplement 15Manufacturing | Approved | None posted |
| May 30, 1997 | Supplement 14Manufacturing | Approved | None posted |
| Sep 27, 1995 | Supplement 13Manufacturing | Approved | None posted |
| Jan 13, 1994 | Supplement 12Labeling | Approved | None posted |
| Jun 9, 1993 | Supplement 11Labeling | Approved | None posted |
| Nov 6, 1992 | Supplement 10Labeling | Approved | None posted |
| Sep 3, 1992 | Supplement 9Manufacturing | Approved | None posted |
| Sep 3, 1992 | Supplement 8Manufacturing | Approved | None posted |
| May 1, 1992 | Supplement 7Labeling | Approved | None posted |
| Sep 11, 1984 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters